Biological H1N1 Vaccines: Too little, too late
Lethality of H1N1 Virus Drops to “Non-Epidemic Resting Levels” in Current Cycle – Virus’ Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessation Biotech firm Replikins Ltd., which has analyzed the H1N1 virus’ genomic data from the 1918 pandemic through the prediction, outbreak, and progress [...]